Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
81.14
-2.77 (-3.30%)
May 15, 2026, 4:00 PM EDT - Market closed
Apogee Therapeutics Employees
Apogee Therapeutics had 261 employees as of December 31, 2025. The number of employees increased by 65 or 33.16% compared to the previous year.
Employees
261
Change (1Y)
65
Growth (1Y)
33.16%
Revenue / Employee
n/a
Profits / Employee
-$1,052,165
Market Cap
6.08B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 261 | 65 | 33.16% |
| Dec 31, 2024 | 196 | 105 | 115.38% |
| Dec 31, 2023 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Corcept Therapeutics | 730 |
| Rhythm Pharmaceuticals | 414 |
| Immunovant | 362 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| Celcuity | 155 |
| CG Oncology | 142 |
APGE News
- 5 days ago - Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 16 days ago - Apogee Therapeutics initiated with a Buy at Rothschild & Co Redburn - TheFly
- 6 weeks ago - Apogee Therapeutics price target raised to $110 from $105 at Mizuho - TheFly
- 7 weeks ago - Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $403 Million - GlobeNewsWire
- 7 weeks ago - Apogee Therapeutics 5M share Secondary priced at $70.00 - TheFly
- 7 weeks ago - Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering - GlobeNewsWire
- 7 weeks ago - Apogee Therapeutics price target raised to $118 from $108 at Deutsche Bank - TheFly
- 7 weeks ago - Apogee Therapeutics price target raised to $160 from $130 at Guggenheim - TheFly